Literature DB >> 7790176

Declining cost-effectiveness of screening for disease. The case of gastric cancer in Japan.

A Babazono1, A L Hillman.   

Abstract

We examined the cost-effectiveness of screening for gastric cancer in hypothetical cohorts of asymptomatic Japanese ages 40, 50, 60, and 70, followed for 10 years. Current screening recommendations in Japan are not optimal. Although indirect x-ray is the correct method, screening for gastric cancer may not be cost-effective for Japanese under the age of 50. Policymakers worldwide should monitor the changing incidence of disease as they consider and recommend screening policies.

Entities:  

Mesh:

Year:  1995        PMID: 7790176     DOI: 10.1017/s0266462300006954

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  3 in total

1.  Cost-effectiveness analysis of dopamine agonists in the treatment of Parkinson's disease in Japan.

Authors:  T Shimbo; K Hira; M Takemura; T Fukui
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale.

Authors:  Bor-Shyang Sheu; Ming-Shiang Wu; Cheng-Tang Chiu; Jing-Chuan Lo; Deng-Chyang Wu; Jyh-Ming Liou; Chun-Ying Wu; Hsiu-Chi Cheng; Yi-Chia Lee; Ping-I Hsu; Chun-Chao Chang; Wei-Lun Chang; Jaw-Town Lin
Journal:  Helicobacter       Date:  2017-01-08       Impact factor: 5.753

3.  Empirical evidence of the continuing improvement in cost efficiency of an endoscopic surveillance programme for gastric cancer in Singapore from 2004 to 2010.

Authors:  Hui Jun Zhou; Shu Chuen Li; Nasheen Naidoo; Feng Zhu; Khay Guan Yeoh
Journal:  BMC Health Serv Res       Date:  2013-04-15       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.